Table 5 Comparison of outcomes 6m after pIOL implantation in group1 and group2
Characteristic | Group1(N = 171 eyes) | Group2 (N = 21 eyes) | P value | P* |
|---|---|---|---|---|
Efficacy | 0.95 (0.83, 1.00) | 0.88 (0.67, 1.00) | 0.1275 | 0.3972 |
Safety | 1.20 (1.00, 1.20) | 1.33 (1.11, 1.43) | 0.0466 | 0.0413 |
BCVA Increase (logMAR) | -0.18 (-0.18, 0.00) | -0.29 (-0.36, -0.11) | 0.0592 | 0.0680 |
BCVA Increase (Line) | 1.00 (0.00, 1.00) | 1.00 (0.00, 1.00) | 0.1654 | 0.1916 |
ECD Loss | 0.01 (-0.04, 0.04) | -0.01 (-0.02, 0.07) | 0.8832 | 0.0728 |
Arch | 500.50 (360.50, 750.50) | 573.00 (333.00, 623.00) | 0.3894 | 0.1690 |
VA (> = 1.0) | 71 (72.5%) | 4 (30.8%) | 0.0059 | 0.0292 |